Table 1.
Introduction |
• First, thank you so much for your time. |
• Can you please describe your involvement in HIV-related research? |
Considerations for diverse pools of participants: |
• What might be some considerations specific to women undergoing ATIs? |
• What might be some considerations for involving minority or diverse populations in ATI studies? |
Additional considerations |
• Do you think HIV treatment interruptions might affect stigma for people living with HIV? |
• Do you think partnership dynamics should be factored in prevention measures during ATIs? |
• How can we best engage people living with HIV around mitigating risks during ATIs? |
• How can we best engage communities around mitigating risks during ATIs? |
Wrap up and closing |
• Would you like to add anything or make additional comments? |
ATI, analytical treatment interruption.